0 of 8 Questions completed
You have already completed this assessment. You cannot start it again.
Assessment is loading…
You must sign in or sign up to take this assessment.
You must first complete the following:
Time has elapsed.
You have completed module three: Therapeutic Use Exemptions.
A list of the resources mentioned in this module is available for download at the end of the tutorial.
You can continue on to module four: Dietary Supplements.
An elite-level patient-athlete who is in the testing pool was warming up for a race and was stung by a wasp. The athlete was beginning to show signs of being in the early stages of anaphylaxis. The patient-athlete has an EpiPen in their kit bag since they commonly carry it for emergency use. What should the athlete do and what best describes the path forward?
Imagine a situation where you are on the team medical support staff for an U-20 women’s basketball team which is traveling to an international competition. You are aware a player has a prescription for an inhaled Beta-2-Agonist (active ingredient salbutamol) to be used as a rescue inhaler in the case of exercise-induced bronchospasm.
This medication is prohibited. [Hint: You may check the status of the substance on GlobalDRO]
You are the team trainer for the Paralympic basketball team. One of your athletes was selected for drug testing after the gold medal game and asked if you would act as his representative.
Are you allowed to do this?
After consulting further with the athlete, you learn that in addition to a Beta-2-Agonist inhaler for her exercise-induced brochospasm, she has been prescribed a medication, classified as a diuretic, to control for acne vulgaris.
Which medication requires a TUE? Beta-2-Agonist inhaler? Diuretic? Or both the Beta-2-Agonist inhaler and the diuretic?
The Paralympic athlete is not ready to provide a sample, but continues to drink fluids. While you wait with the athlete, you discuss the athlete’s medical history. You notice that the Doping Control Officer (DCO) is still around and listening to your conversation. You don’t like this and politely ask the DCO to leave.
What will his response be?
The athlete provides a sample, but is having trouble pouring the urine sample into the collection bottles. The athlete asks for your help.
Are you allowed to do this?
The sample collection process is almost complete and the only thing left to finish is the paperwork. The athlete signs his name and the DCO signs his name, but states you do not have to sign the paperwork. You casually nod and leave the doping control station. Upon leaving the gym, you feel uneasy and like something is missing.
Should you have signed the paperwork?
A patient-athlete completed and long-course triathlon and placed second but immediately went to the medical tent where her/his blood pressure had dropped significantly and she/he could not retain oral fluid hydration. The patient-athlete’s condition continued to decline and she/he was given an 1000mL N/S IV infusion before transported via ambulance to a hospital ER where she then received an additional 1000 mL N/S IV infusion with Phenergan in addition to oral ibuprofen. Does your patient-athlete need a TUE and for what substances/methods?